270 related articles for article (PubMed ID: 36573102)
1. Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.
Feldman M; Marmol S; Margolesky J
Ther Clin Risk Manag; 2022; 18():1129-1142. PubMed ID: 36573102
[TBL] [Abstract][Full Text] [Related]
2. Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.
Shin HW; Hong SW; Youn YC
J Clin Neurol; 2022 May; 18(3):259-270. PubMed ID: 35589315
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced parkinsonism.
Shin HW; Chung SJ
J Clin Neurol; 2012 Mar; 8(1):15-21. PubMed ID: 22523509
[TBL] [Abstract][Full Text] [Related]
4. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
Munhoz RP; Bertucci Filho D; Teive HA
Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced parkinsonism in the elderly: incidence, management and prevention.
López-Sendón JL; Mena MA; de Yébenes JG
Drugs Aging; 2012 Feb; 29(2):105-18. PubMed ID: 22250585
[TBL] [Abstract][Full Text] [Related]
6. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced parkinsonism.
Susatia F; Fernandez HH
Curr Treat Options Neurol; 2009 May; 11(3):162-9. PubMed ID: 19364450
[TBL] [Abstract][Full Text] [Related]
8. Parkinsonism in the psychiatric setting: an update on clinical differentiation and management.
Powell A; Gallur L; Koopowitz L; Hayes MW
BMJ Neurol Open; 2020; 2(1):e000034. PubMed ID: 33681781
[TBL] [Abstract][Full Text] [Related]
9. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
Oh YS; Kwon DY; Kim JS; Park MH; Berg D
Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
[TBL] [Abstract][Full Text] [Related]
10. Waveform analysis of tremor may help to differentiate Parkinson's disease from drug-induced parkinsonism.
Jang W; Han J; Park J; Kim JS; Cho JW; Koh SB; Chung SJ; Kim IY; Kim HT
Physiol Meas; 2013 Mar; 34(3):N15-24. PubMed ID: 23442947
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea.
Han S; Kim S; Kim H; Shin HW; Na KS; Suh HS
BMC Public Health; 2019 Oct; 19(1):1328. PubMed ID: 31640652
[TBL] [Abstract][Full Text] [Related]
12. Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?
Lim TT; Ahmed A; Itin I; Gostkowski M; Rudolph J; Cooper S; Fernandez HH
Int J Neurosci; 2013 Mar; 123(3):170-4. PubMed ID: 23078283
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism.
Kotomin I; Korotkov A; Solnyshkina I; Didur M; Cherednichenko D; Kireev M
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611366
[TBL] [Abstract][Full Text] [Related]
14. Drug-Induced Parkinsonism: Too Many Cooks in the Kitchen.
Liotta M; Bell H; Vu AT; Stillman M
Cureus; 2023 Sep; 15(9):e44896. PubMed ID: 37814773
[TBL] [Abstract][Full Text] [Related]
15. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
[TBL] [Abstract][Full Text] [Related]
16. Non-motor extranigral signs and symptoms in Parkinson's disease.
Wolters ECh
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
[TBL] [Abstract][Full Text] [Related]
17. [Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease].
Errea-Abad JM; Ara-Callizo JR; Aibar-Remón C
Rev Neurol; 1998 Jul; 27(155):35-9. PubMed ID: 9674021
[TBL] [Abstract][Full Text] [Related]
18. A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson's disease in a bipolar patient.
Hermida AP; Janjua AU; Glass OM; Vaughan CP; Goldstein F; Trotti LM; Factor SA
Int Psychogeriatr; 2016 Dec; 28(12):2101-2104. PubMed ID: 27517671
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of manganese-induced parkinsonism.
Cersosimo MG; Koller WC
Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
